OBJECTIVE: To investigate whether cognitive impairment in multiple sclerosis (MS) patients is associated to different patterns of gray matter (GM) atrophy and T2-visible lesion distribution according to the clinical phenotype. EXPERIMENTAL DESIGN: Twenty-two relapsing remitting (RR), 29 secondary progressive (SP), and 22 primary progressive (PP) MS patients, and 39 healthy controls underwent high-field structural magnetic resonance imaging and an extensive neuropsychological battery. Voxel-wise distribution of GM damage and T2-lesions was compared between cognitively impaired (CI) and cognitively preserved (CP) patients according to their clinical phenotype. PRINCIPAL OBSERVATIONS: Thirty-nine MS patients were CI. In all MS groups, regional GM loss was correlated with cognitive impairment. Different patterns of regional distribution of GM atrophy and T2-visible lesions were found between CI vs. CP MS patients, according to their clinical phenotype. No areas were significantly more atrophied in CI SPMS vs. CI RRMS patients. Conversely, compared with CI PPMS, CI SPMS patients had a significant GM loss in several regions of the fronto-temporal lobes, the left hypothalamus and thalami. While in RRMS and SPMS patients there was a correspondence between presence of T2 visible lesions and GM atrophy in several areas, this was not the case in PPMS patients. CONCLUSION: Distinct patterns of regional distribution of GM damage and T2-visible lesions are associated with cognitive impairment in MS patients with different clinical phenotypes. The correspondence between lesion formation and GM atrophy distribution varies in the different forms of MS.
OBJECTIVE: To investigate whether cognitive impairment in multiple sclerosis (MS) patients is associated to different patterns of gray matter (GM) atrophy and T2-visible lesion distribution according to the clinical phenotype. EXPERIMENTAL DESIGN: Twenty-two relapsing remitting (RR), 29 secondary progressive (SP), and 22 primary progressive (PP) MSpatients, and 39 healthy controls underwent high-field structural magnetic resonance imaging and an extensive neuropsychological battery. Voxel-wise distribution of GM damage and T2-lesions was compared between cognitively impaired (CI) and cognitively preserved (CP) patients according to their clinical phenotype. PRINCIPAL OBSERVATIONS: Thirty-nine MSpatients were CI. In all MS groups, regional GM loss was correlated with cognitive impairment. Different patterns of regional distribution of GM atrophy and T2-visible lesions were found between CI vs. CPMSpatients, according to their clinical phenotype. No areas were significantly more atrophied in CI SPMS vs. CI RRMSpatients. Conversely, compared with CI PPMS, CI SPMSpatients had a significant GM loss in several regions of the fronto-temporal lobes, the left hypothalamus and thalami. While in RRMS and SPMS patients there was a correspondence between presence of T2 visible lesions and GM atrophy in several areas, this was not the case in PPMS patients. CONCLUSION: Distinct patterns of regional distribution of GM damage and T2-visible lesions are associated with cognitive impairment in MSpatients with different clinical phenotypes. The correspondence between lesion formation and GM atrophy distribution varies in the different forms of MS.
Authors: R H C Lazeron; J B Boringa; M Schouten; B M J Uitdehaag; E Bergers; J Lindeboom; M I Eikelenboom; P H Scheltens; F Barkhof; C H Polman Journal: Mult Scler Date: 2005-10 Impact factor: 6.312
Authors: J Mazziotta; A Toga; A Evans; P Fox; J Lancaster; K Zilles; R Woods; T Paus; G Simpson; B Pike; C Holmes; L Collins; P Thompson; D MacDonald; M Iacoboni; T Schormann; K Amunts; N Palomero-Gallagher; S Geyer; L Parsons; K Narr; N Kabani; G Le Goualher; D Boomsma; T Cannon; R Kawashima; B Mazoyer Journal: Philos Trans R Soc Lond B Biol Sci Date: 2001-08-29 Impact factor: 6.237
Authors: Emilio Portaccio; Benedetta Goretti; Valentina Zipoli; Benedetta Nacmias; Maria Laura Stromillo; Maria Letizia Bartolozzi; Gianfranco Siracusa; Leonello Guidi; Antonio Federico; Sandro Sorbi; Nicola De Stefano; Maria Pia Amato Journal: Mult Scler Date: 2009-11-13 Impact factor: 6.312
Authors: Maria Pia Amato; Emilio Portaccio; Benedetta Goretti; Valentina Zipoli; Marco Battaglini; Maria Letizia Bartolozzi; Maria Laura Stromillo; Leonello Guidi; Gianfranco Siracusa; Sandro Sorbi; Antonio Federico; Nicola De Stefano Journal: Arch Neurol Date: 2007-08
Authors: M Bester; J H Jensen; J S Babb; A Tabesh; L Miles; J Herbert; R I Grossman; M Inglese Journal: Mult Scler Date: 2014-11-12 Impact factor: 6.312
Authors: Maria A Rocca; Marco Battaglini; Ralph H B Benedict; Nicola De Stefano; Jeroen J G Geurts; Roland G Henry; Mark A Horsfield; Mark Jenkinson; Elisabetta Pagani; Massimo Filippi Journal: Neurology Date: 2016-12-16 Impact factor: 9.910
Authors: Regina Schlaeger; Nico Papinutto; Valentina Panara; Carolyn Bevan; Iryna V Lobach; Monica Bucci; Eduardo Caverzasi; Jeffrey M Gelfand; Ari J Green; Kesshi M Jordan; William A Stern; H-Christian von Büdingen; Emmanuelle Waubant; Alyssa H Zhu; Douglas S Goodin; Bruce A C Cree; Stephen L Hauser; Roland G Henry Journal: Ann Neurol Date: 2014-08-21 Impact factor: 10.422
Authors: D Damjanovic; P Valsasina; M A Rocca; M L Stromillo; A Gallo; C Enzinger; H E Hulst; A Rovira; N Muhlert; N De Stefano; A Bisecco; F Fazekas; M J Arévalo; T A Yousry; M Filippi Journal: AJNR Am J Neuroradiol Date: 2016-09-29 Impact factor: 3.825